| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $421.0M | +4.1% |
| Cost of Revenue | $96.4M | +10.2% |
| Gross Profit | $324.6M | +2.4% |
| R&D Expense | $77.2M | +7.2% |
| SG&A Expense | $105.1M | +45.5% |
| Operating Income | -$32.4M | -423.3% |
| Pre-tax Income | -$28.1M | -8201.2% |
| Income Tax | -$110K | -104.8% |
| Net Income | -$27.9M |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $123.1M | -41.4% |
| Accounts Receivable | $112.9M | +4.4% |
| Current Assets | $285.8M | -20.6% |
| Total Assets | $610.1M | +19.9% |
| Current Liabilities | $344.7M | +28.7% |
| Total Liabilities | $456.9M | +26.3% |
| Stockholders' Equity | $153.2M | +4.1% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $50.2M | +8.8% |
| Capital Expenditures | $2.1M | -23.6% |
| Investing Cash Flow | -$91.5M | -3253.8% |
| Financing Cash Flow | -$28.5M | -22.7% |
| Free Cash Flow | $48.1M | +10.8% |
| -962.7% |
| EPS (Basic) | -$0.22 | -1000.0% |
| EPS (Diluted) | -$0.22 | -1000.0% |